» Articles » PMID: 28778682

Performance of the PSI and CURB-65 Scoring Systems in Predicting 30-day Mortality in Healthcare-associated Pneumonia

Overview
Journal Med Clin (Barc)
Specialty General Medicine
Date 2017 Aug 6
PMID 28778682
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Healthcare-associated pneumonia (HCAP) is the leading cause of infection in a hospital setting and is associated with a high mortality rate. This study aimed to evaluate the performance of the pneumonia severity index (PSI) and confusion, urea, respiratory rate, blood pressure, age≥65 (CURB-65) systems in predicting 30-day mortality in HCAP in adult patients.

Patients And Methods: A cross-sectional study took place and data from 109 non-immunocompromised individuals aged>18 years were analyzed. The clinical diagnosis of HCAP included the presence of radiographic infiltrates in patients≥48hours after hospital admission. The PSI and CURB-65 scores were calculated and performance measures were estimated. Summary statistics were used to describe the study sample. The PSI and CURB-65 scores were calculated based on 20 and 5 criteria, respectively, and the performance indicators of the screening tools were estimated.

Results: The overall 30-day mortality was 59.6%. At every given threshold, PSI sensitivity was higher, but showed a lower specificity than the CURB-65, and the highest Youden index (0.392) was observed at cut-off V in the PSI. The area under the ROC curve was 0.737 (95% CI: 0.646-0.827) and 0.698 (95% CI: 0.600-0.797) using the PSI and CURB-65 systems, respectively (P=.323).

Conclusion: Our findings suggest that the performance of the PSI and CURB-65 is reasonable for predicting 30-day mortality in adult HCAP patients and may be used in healthcare settings.

Citing Articles

Development of a new prognostic model to predict pneumonia outcome using artificial intelligence-based chest radiograph results.

Shin H, Lee E, Han K, Ryu L, Kim E Sci Rep. 2024; 14(1):14415.

PMID: 38909087 PMC: 11193777. DOI: 10.1038/s41598-024-65488-1.


Utility of pneumonia severity assessment tools for mortality prediction in healthcare-associated pneumonia: a systematic review and meta-analysis.

Noguchi S, Katsurada M, Yatera K, Nakagawa N, Xu D, Fukuda Y Sci Rep. 2024; 14(1):12964.

PMID: 38839837 PMC: 11153623. DOI: 10.1038/s41598-024-63618-3.


The role of pre-onset hair hormone in predicting the prognosis of patients with severe pneumonia and acute COVID-19 outbreak.

Jia Y, Qi D, Wang T, Zhang Y, Chen X, Deng H Heliyon. 2024; 10(9):e30636.

PMID: 38765161 PMC: 11098831. DOI: 10.1016/j.heliyon.2024.e30636.


CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study.

Carriel J, Munoz-Jaramillo R, Bolanos-Ladinez O, Heredia-Villacreses F, Menendez-Sanchon J, Martin-Delgado J Rev Clin Esp (Barc). 2022; 222(1):37-41.

PMID: 34996587 PMC: 8086802. DOI: 10.1016/j.rceng.2020.10.006.


Prevalence of clinical and radiologic features in methanol-poisoned patients with and without COVID-19 infection.

Zamani N, Gheshlaghi F, Haghighi-Morad M, Bahrami-Motlagh H, Alavi Darazam I, Hadeiy S Acute Med Surg. 2021; 8(1):e715.

PMID: 34925862 PMC: 8647202. DOI: 10.1002/ams2.715.